ONVO - Bullish Move Inbound? Breakout Likely

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

SHORT INTEREST
5.65M 09/13/19

P/E Current
-1.21

P/E Ratio (with extraordinary items)
-1.39

Average Recommendation: HOLD

Average Target Price: 1.50